{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:38:58Z","timestamp":1789911538610,"version":"4.0.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2018.00418","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T05:40:14Z","timestamp":1545111614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Nitrendipine and Dementia: Forgotten Positive Facts?"],"prefix":"10.3389","volume":"10","author":[{"given":"Michal","family":"Novotny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka","family":"Klimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Valis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"B1","unstructured":"Dementia\n            AgamanolisD.\n          2012"},{"key":"B2","first-page":"332","article-title":"Alzheimer\u2019s disease facts and figures","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345791","article-title":"A review: treatment of Alzheimer\u2019s disease discovered in repurposed agents","volume":"35","author":"Appleby","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","article-title":"Selective dihydropyiridine compounds facilitate the clearance of \u03b2-amyloid across the blood-brain barrier","volume":"659","author":"Bachmeier","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/HYPERTENSIONAHA.112.193672","article-title":"Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia","volume":"60","author":"Capone","year":"2012","journal-title":"Hypertension"},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer\u2019s disease","volume":"351","author":"Cummings","year":"2004","journal-title":"N Engl. J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2018.02.007","article-title":"Alzheimer\u2019s disease drug development pipeline: 2018","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers. Dement. N Y"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/0735-1097(94)90140-6","article-title":"Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease double-blind circadian anti-ischemia program in europe (CAPE Trial)","volume":"24","author":"Deanfield","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/msj.20155","article-title":"Role of vascular risk factors and vascular dysfunction in Alzheimer\u2019s disease","volume":"77","author":"Dickstein","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e000091","DOI":"10.1161\/JAHA.111.000091","article-title":"Cerebrovascular consequences of obstructive sleep apnea","volume":"1","author":"Durgan","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/HYPERTENSIONAHA.111.186429","article-title":"Hypertension and cognitive functioning: a perspective in historical context","volume":"60","author":"Elias","year":"2012","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a116868","article-title":"Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"B14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","article-title":"Hypertension: a harbinger of stroke and dementia","volume":"62","author":"Faraco","year":"2013","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0895-4356(90)90136-d","article-title":"Longitudinally measured blood pressure, antihypertensive medication use and cognitive performance: the Framingham Study","volume":"43","author":"Farmer","year":"1990","journal-title":"J. Clin. Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch. Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"172S","DOI":"10.1016\/s0895-7061(96)90097-7","article-title":"Calcium channel antagonists: friend or foe in postinfarction patients?","volume":"9","author":"Gibson","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"B19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/bmj.312.7034.805","article-title":"Low blood pressure and dementia in elderly people: the kungsholmen project","volume":"312","author":"Guo","year":"1996","journal-title":"BMJ"},{"key":"B20","first-page":"649","article-title":"Hypertension in the elderly and risk of dementia","volume":"60","author":"Hanon","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00019501-199401000-00004","article-title":"Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction","volume":"5","author":"Held","year":"1994","journal-title":"Coron. Artery Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"18759","DOI":"10.1074\/jbc.272.30.18759","article-title":"Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the \u03b11 subunit","volume":"272","author":"Hockerman","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1044\/policy.gl1991-00051","article-title":"Speech and language impairments in dementia","volume":"14","author":"Klimova","year":"2016","journal-title":"J. Appl. Biomed."},{"key":"B24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/NDT.S95903","article-title":"Assistive technologies in managing language disorders in dementia","volume":"12","author":"Klimova","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/CIA.S89714","article-title":"Alzheimer\u2019s disease and language impairments: social intervention and medical treatment","volume":"10","author":"Klimova","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signaling in Alzheimer\u2019s Disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3109\/10641969309037083","article-title":"MRC trial of treatment in elderly hypertensives","volume":"15","author":"Lever","year":"1993","journal-title":"Clin. Exp. Hypertens."},{"key":"B29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/01.hjh.0000059028.82022.89","article-title":"The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J. Hypertens."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3233\/JAD-160484","article-title":"Alzheimer\u2019s and Parkinson\u2019s diseases: expected economic impact on europe\u2014a call for a uniform european strategy","volume":"54","author":"Maresova","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/bmj.319.7213.806b","article-title":"Calcium-channel blockers and cognitive function in elderly people: results from the Canadian study of health and aging","volume":"161","author":"Maxwell","year":"1999","journal-title":"CMAJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1600-0447.2011.01730.x","article-title":"Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy","volume":"124","author":"Mitchell","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"B33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.1996.tb05871.x","article-title":"Classification of dementia and Alzheimer\u2019s disease","volume":"165","author":"Morris","year":"1996","journal-title":"Acta Neurol. Scand."},{"key":"B34","doi-asserted-by":"publisher","first-page":"M130","DOI":"10.1093\/gerona\/55.3.M130","article-title":"The cross-sectional association between blood pressure and Alzheimer\u2019s disease in a biracial community population of older persons","volume":"55","author":"Morris","year":"2000","journal-title":"J. Gerontol. A"},{"key":"B35","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/00004872-199512010-00068","article-title":"The progress study: rationale and design","volume":"13","author":"Neal","year":"1995","journal-title":"J. Hypertens."},{"key":"B36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/v10136-011-0013-4","article-title":"Neurodegenerative diseases and neuroprotection: current views and prospects","volume":"9","author":"Nieoullon","year":"2011","journal-title":"J. Appl. Biomed."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1073\/pnas.1300021110","article-title":"Innate immunity receptor CD36 promotes cerebral amyloid angiopathy","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/fca.15.90","article-title":"The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis","volume":"12","author":"Parsons","year":"2016","journal-title":"Future Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.cir.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000212832","article-title":"The pathophysiology of dementia","volume":"32","author":"Plum","year":"1986","journal-title":"Gerontology"},{"key":"B44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/WNL.44.1.97","article-title":"Risk factors for Alzheimer\u2019s disease and dementia: a case control study based on the MRC elderly hypertension trial","volume":"44","author":"Prince","year":"1994","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000089515","article-title":"Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors","volume":"21","author":"Ravaglia","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur. Heart J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000051233","article-title":"Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study","volume":"12","author":"Ruitenberg","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0006-8993(93)90505-h","article-title":"Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer\u2019s Parkinson\u2019s and Huntington\u2019s diseases","volume":"611","author":"Sen","year":"1993","journal-title":"Brain Res."},{"key":"B50","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s11906-012-0315-2","article-title":"Hypertension and mild cognitive impairment","volume":"14","author":"Sierra","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.7326\/0003-4819-116-8-615","article-title":"Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients","volume":"116","author":"Skinner","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"B53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/hypertensionaha.110.165142","article-title":"Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia","volume":"57","author":"Staessen","year":"2011","journal-title":"Hypertension"},{"key":"B55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1097\/00005344-198806121-00012","article-title":"Early treatment of unstable angina with nifedipine and metoprolol- the HINT trial","volume":"12","author":"Tijssen","year":"1988","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.113.00147","article-title":"Is hypertension associated with an accelerated aging of the brain?","volume":"63","author":"Tzourio","year":"2014","journal-title":"Hypertension"},{"key":"B58","unstructured":"Dementia2017"},{"key":"B59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the Baltimore longitudinal study of aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol. Aging"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T05:40:28Z","timestamp":1545111628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":59,"alternative-id":["10.3389\/fnagi.2018.00418"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2018.00418","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]},"article-number":"418"}}